Dishman Pharmaceuticals and Chemicals has received Establishment Inspection Report (EIR) from the USFDA for its Bavla facility on February 01, 2017. Thus, the company’s facilities in Bavla, Naroda and Switzerland continue to be approved by the USFDA. The US Food and Drug Administration (USFDA) had inspected Bavla facility in July, 2016.

Dishman Pharmaceuticals and Chemicals is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and manufacturing services. It improves its customers’ businesses by providing a range of development and manufacturing solutions at locations in Europe and in India.


Peers
Company Name CMP
Sun Pharma Inds. 1491.00
Dr. Reddys Lab 5976.80
Cipla 1382.40
Zydus Lifesciences 935.25
Lupin 1584.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.